GCP
XBIT icon

GSA Capital Partners’s XBiotech XBIT Stock Holding History

GSA Capital Partners’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71K Buy
+30,654
New +$74.2K ﹤0.01% 1646
2016
Q2 		– Sell
-17,115
Closed -$162K – 1945
2016
Q1 		$162K Buy
17,115
+2,400
+16% +$19.9K 0.01% 1534
2015
Q4 		$160K Buy
+14,715
New +$188K 0.01% 1684

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GSA Capital Partners's XBIT Position: Q2 2026 in Review

GSA Capital Partners opened a new position in XBiotech (XBIT) in Q2 2026: 30,654 shares worth $71K. The stake represents ﹤0.01% of the portfolio and ranks #1646 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in XBIT as recently as Q1 2016.

GSA Capital Partners first reported a position in XBIT in Q4 2015 and has held it in 3 quarters since. The position peaked at $162K in Q1 2016. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • GSA Capital Partners held 30,654 shares of XBiotech worth $71K as of Q2 2026.
  • XBiotech was a new GSA Capital Partners position in Q2 2026.
  • XBiotech made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1646 holding.
  • GSA Capital Partners first reported a position in XBiotech in Q4 2015 and has held it in 3 quarters since.
  • GSA Capital Partners's XBiotech position peaked at $162K in Q1 2016.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.